Wall Street Journal -- Drugmakers and the FDA are talking about whether epilepsy drugs increase the risk of suicidal behavior, the WSJ reports. According to agency data on 11 epilepsy drugs on the market, 0.37% of patients who took one of the drugs in clinical trials showed signs of suicidal behavior, compared with 0.23% of the patients who took placebos.
